Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Patients and data tracking

- PMLiVE

GSK files melanoma drug candidates in EU and US

Submits BRAF inhibitor dabrafenib and MEK inhibitor trametinib

BMI Healthcare hires Doctors.net.uk to raise awareness of services

Online physician community will highlight BMI Healthcare services where treatments are unavailable on the NHS

Kai Gait returns to GSK as digital marketing director

He will be developing digital channel materials and services, built on customer insights

Generics account for 80 per cent of US prescriptions

IMS Health study finds savings of $193bn last year

Astellas to close US urology research facility

Work at Urogenix, North Carolina site will end by the end of the year

- PMLiVE

AstraZeneca UK launches Prostate Assistant mobile app

iPhone, iPad and Android app aims to help men with prostate cancer

Boehringer to manufacture Servier’s gevokizumab

Will produce inflammatory disease drug at its Biberach facility

Executive changes at Teva as community and institutional affairs division launched

Dr Carlo De Notaristefani joins as president and CEO of global operations while Arik Yaari will head new division

Gilead Sciences

Gilead works with Indian generic firms to improve HIV drug access

Collaboration with Mylan, Ranbaxy and Strides aims to reduce cost of emtricitabine

Modern anticoagulants threaten status quo

Could the shift towards first-in-class novel oral treatments, which are expected to prove beneficial for prevention of stroke caused by AF, render warfarin obselete?

Teva sees Q2 profits leap as US business recovers

Offsets weaker performance in Europe

- PMLiVE

UK drug pricing negotiations will begin next month

ABPI and DH confirm date and outline topics of discussion for implementing VBP

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links